Home » Authors » Lynn Yoffee

Lynn Yoffee

lynn.yoffee@clarivate.com

Articles

ARTICLES

Deals roundup: Spectranetics acquires Kensey Nash's endovascular unit for $24M

May 14, 2008

World Heart defaults under $5M note issued to Abiomed

May 13, 2008

Covidien wins FDA approval of contrast system with RFID

May 12, 2008

Medtronic's wireless glucose meter receives okay from FDA

May 8, 2008

Cryptography Research's tech takes aim at device 'cloning'

May 8, 2008

Deals roundup: Bristol-Myers agrees to sell its ConvaTec unit for $4.1B

May 6, 2008

Oxycyte on track as oxygen carrier, not blood substitute

May 5, 2008

Medtronic's wireless glucose meter receives okay from FDA

May 1, 2008

Nanotechnology sector has its growing pains

May 1, 2008

Oxycyte is on track as oxygen carrier, not as 'faux' blood

May 1, 2008

View All Articles by Lynn Yoffee

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan. 2, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for January 2, 2025
Ionis notches Arrowhead win; Tryngolza cleared for FCS
BioWorld
Ionis Pharmaceuticals Inc. CEO Brett Monia predicted that diagnoses of familial chylomicronemia syndrome (FCS) will “accelerate fairly quickly” now that the firm...
NRP1 is NGF/TrkA partner in crime in pain signaling
BioWorld Science
Chronic pain affects about 20% of the population worldwide. It is – inadequately – treated with nonsteroidal anti-inflammatory compounds and opioids that lack...
STAT6 stat sig? Kaken, J&J $1.2B-plus deal adds oomph to space
BioWorld
Kaken Pharmaceutical Co. Ltd.’s license agreement with Johnson & Johnson (J&J) for signal transducer and activator of transcription (STAT)6 inhibitor KP-723 could...

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.